Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Low total testosterone and low DHEA-S reflect reduced ovarian/adrenal androgen production and lower free testosterone.

Low total testosterone and low DHEA-S indicate reduced ovarian and adrenal androgen output, which leads to a lower concentration of biologically active free testosterone.

SupportedJune 19, 202612 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Low total testosterone and low DHEA-S reflect reduced ovarian/adrenal androgen production, which can contribute to low free testosterone.

laying out figure…
All 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that low circulating total testosterone and DHEA-S reflect diminished steroidogenic output from the ovaries and adrenals, with DHEA-S serving as a specific adrenal marker. Because free testosterone is the small unbound fraction of the total androgen pool, a reduced total pool—exacerbated by less precursor substrate for peripheral conversion—directly lowers the free testosterone concentration unless binding protein levels change substantially.

Verified conclusion

The relationship between total testosterone, DHEA-S, and the biologically active free testosterone fraction is well-established in female physiology. In a 30-year-old female, these markers serve as specific indicators of the functional output of the endocrine glands and the peripheral tissues that convert precursors into active androgens.

Mechanisms of androgen production

The female androgen pool is derived from three primary sources: direct ovarian secretion, direct adrenal secretion, and the peripheral conversion of pro-hormones.

  • DHEA-S as an adrenal marker: DHEA-S is almost exclusively produced (90–100%) by the zona reticularis of the adrenal cortex. Consequently, low DHEA-S is a highly specific biomarker for reduced adrenal androgenic activity.
  • Total testosterone sources: Circulating total testosterone is produced roughly 25% by the ovaries (theca cells) and 25% by the adrenal glands. The remaining 50% is synthesized in peripheral tissues (adipose, skin, and liver) through the conversion of precursors, primarily androstenedione and DHEA-S.
  • Glandular insufficiency: Low levels of these hormones typically reflect a decline in the steroidogenic capacity of these glands, such as in cases of adrenal insufficiency or reduced ovarian reserve.

Impact on free testosterone levels

Free testosterone (FT) represents the small fraction (typically 1–2%) of testosterone not bound to Sex Hormone-Binding Globulin (SHBG) or albumin. It is the primary driver of androgenic signaling at the cellular level.

  • Mathematical dependency: According to the Free Hormone Hypothesis and the Vermeulen equation, the concentration of free testosterone is directly dependent on the total testosterone pool. If total production from the ovaries and adrenals decreases, the available free fraction must also decrease, unless there is a simultaneous and significant drop in SHBG.
  • Precursor substrate availability: DHEA-S acts as a critical reservoir for intracrine androgen production. Reduced adrenal output of DHEA-S limits the substrate available for peripheral conversion into testosterone, further contributing to low total and free testosterone concentrations.

Bottom line

Low total testosterone and DHEA-S are reliable indicators of reduced ovarian and adrenal output. Because free testosterone is a subset of the total androgen pool, a reduction in these primary androgens directly diminishes the concentration of biologically active free testosterone.

References

  1. Diagnostic pitfalls in ovarian androgen-secreting tumors in postmenopausal women with rapidly progressed severe hyperandrogenism — journals.sagepub.com ↗
  2. Involvement of androgens in ovarian health and disease. — pmc.ncbi.nlm.nih.gov ↗
  3. Practical Approach to Hyperandrogenism in Women. — pmc.ncbi.nlm.nih.gov ↗
  4. ODP056 The Treatment of Opioid Addiction Leading to Secondary Adrenal Insufficiency — academic.oup.com ↗
  5. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. — academic.oup.com ↗
  6. Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilization — pmc.ncbi.nlm.nih.gov ↗
  7. Reassessing Free-Testosterone Calculation by Liquid Chromatography–Tandem Mass Spectrometry Direct Equilibrium Dialysis — academic.oup.com ↗
  8. Validity of free testosterone calculation in pregnant women — ec.bioscientifica.com ↗
  9. Chrysin’s dose-dependent effects on steroidogenesis in female BALB/c mice: In vivo study of adrenal, ovarian, and uterine hormone regulation — pharmacia.pensoft.net ↗
  10. Physiological and Pathological Androgen Actions in the Ovary. — pmc.ncbi.nlm.nih.gov ↗
  11. Intracrine Formation of Steroid Hormones in Breast Cancer, Epidermal Keratinocyte, Dermal Fibroblast, and Adipocyte Cell Lines Measured by LC-MS/MS — pmc.ncbi.nlm.nih.gov ↗
  12. Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial — bmcwomenshealth.biomedcentral.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→